SELECT * FROM `stock_list` where symbol='QIA' AND exchange = 'XTER' limit 0,1
SELECT * FROM `stock_list` where symbol='QIA' AND exchange = 'XTER' limit 0,1
SELECT * FROM `stock_list` WHERE `symbol` = "QIA" and stock_list.exchange IN (SELECT exchange FROM gurufocu_main.stock_list_exchanges where country='USA' and active=1) limit 0,1 Qiagen NV (XTER:QIA) Cyclically Adjusted Revenue per Share
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (XTER:QIA) » Definitions » Cyclically Adjusted Revenue per Share

Qiagen NV (XTER:QIA) Cyclically Adjusted Revenue per Share : €7.77 (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Qiagen NV Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Qiagen NV's adjusted revenue per share for the three months ended in Dec. 2023 was €2.086. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €7.77 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Qiagen NV's average Cyclically Adjusted Revenue Growth Rate was 2.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 8.10% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 6.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Qiagen NV was 15.70% per year. The lowest was 4.20% per year. And the median was 8.65% per year.

As of today (2024-05-01), Qiagen NV's current stock price is €39.08. Qiagen NV's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was €7.77. Qiagen NV's Cyclically Adjusted PS Ratio of today is 5.03.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Qiagen NV was 8.75. The lowest was 4.11. And the median was 5.69.


Qiagen NV Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Qiagen NV's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Cyclically Adjusted Revenue per Share Chart

Qiagen NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.66 5.30 6.50 7.85 7.77

Qiagen NV Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.85 7.63 7.75 8.13 7.77

Competitive Comparison of Qiagen NV's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, Qiagen NV's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qiagen NV's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Cyclically Adjusted PS Ratio falls into.



Qiagen NV Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Qiagen NV's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.086/126.4000*126.4000
=2.086

Current CPI (Dec. 2023) = 126.4000.

Qiagen NV Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 1.010 99.390 1.284
201406 1.083 99.240 1.379
201409 1.158 99.960 1.464
201412 1.271 99.050 1.622
201503 1.244 99.750 1.576
201506 1.286 100.230 1.622
201509 1.265 100.500 1.591
201512 1.224 99.730 1.551
201603 1.159 100.310 1.460
201606 1.286 100.260 1.621
201609 1.300 100.570 1.634
201612 1.495 100.710 1.876
201703 1.263 101.440 1.574
201706 1.376 101.370 1.716
201709 1.353 102.030 1.676
201712 1.492 101.970 1.849
201803 1.235 102.470 1.523
201806 1.424 103.100 1.746
201809 1.420 103.950 1.727
201812 1.572 103.970 1.911
201903 1.362 105.370 1.634
201906 1.496 105.840 1.787
201909 1.581 106.700 1.873
201912 1.684 106.800 1.993
202003 1.495 106.850 1.769
202006 1.734 107.510 2.039
202009 1.796 107.880 2.104
202012 2.061 107.850 2.415
202103 2.114 108.870 2.454
202106 2.093 109.670 2.412
202109 2.019 110.790 2.303
202112 2.293 114.010 2.542
202203 2.556 119.460 2.704
202206 2.186 119.050 2.321
202209 2.261 126.890 2.252
202212 2.104 124.940 2.129
202303 2.050 124.720 2.078
202306 2.043 125.830 2.052
202309 1.993 127.160 1.981
202312 2.086 126.400 2.086

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Qiagen NV  (XTER:QIA) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Qiagen NV's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=39.08/7.77
=5.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Qiagen NV was 8.75. The lowest was 4.11. And the median was 5.69.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Qiagen NV Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Qiagen NV (XTER:QIA) Business Description

Industry
Address
Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Qiagen NV (XTER:QIA) Headlines

No Headlines